Nalaganje...

Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia

AIMS/HYPOTHESIS: Heterozygous glucokinase (GCK) mutations cause mild, fasting hyperglycaemia from birth. Although patients are usually asymptomatic and have glycaemia within target ranges, some are put on pharmacological treatment. We aimed to investigate how many patients are on pharmacological tre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Stride, Amanda, Shields, Beverley, Gill-Carey, Olivia, Chakera, Ali J., Colclough, Kevin, Ellard, Sian, Hattersley, Andrew T.
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3855531/
https://ncbi.nlm.nih.gov/pubmed/24092492
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-013-3075-x
Oznake: Označite
Brez oznak, prvi označite!